Oxford BioTherapeutics, WuXi Biologics team up to create cancer antibodies

12th December 2018 Uncategorised 0

Oxford BioTherapeutics has entered a strategic partnership with WuXi Biologics to develop bispecific antibodies for the treatment of several cancer types, expanding on the existing collaboration between the two.

More: Oxford BioTherapeutics, WuXi Biologics team up to create cancer antibodies
Source: News